loder

Middle East and Africa Anthrax Vaccine Market

Middle East and Africa Anthrax Vaccine Market - By Type: Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines; By Application: Pre-exposure Vaccination, Post-exposure Vaccination; By End-user: Military, Government, Healthcare Providers, Others; By Country: Kingdom of Saudi Arabia (KSA), United Arab Emirates (UAE), Qatar, South Africa, Egypt, Israel, Turkey, Nigeria, Kenya, Oman, Kuwait, Bahrain, Morocco, Algeria, Jordan and Rest of Middle East and Africa

Report Code
CVMI29125069
Published
March 26, 2025
Last Updated
March 26, 2025
Coverage
Healthcare • Healthcare
Analyst-led, consultative delivery
Enterprise-ready licensing options
Fast turnarounds for custom cuts

Market Snapshot

High-signal KPIs designed for executive scanning.
Indicative snapshot. Request sample for full model outputs.
Market Size (latest)
vs. prior year
CAGR
Forecast window:
Forecast Period
2024–2031
Base years: 2019–2023
Coverage Depth
Segments • Regions • Players

Insights

Consultative narrative + actionable decision support.
Preview available upon request.
Get sample pages, TOC and analyst summary.
Unlock the executive summary.
Request the sample to review key questions answered.
See what’s included.
Request sample for scope, definitions and segmentation.

Key Players

  • Anthrax Vaccine Market – Emergent BioSolutions Inc.
  • Merck & Co. Inc.
  • Zoetis Inc.
  • Bayer AG
  • Elanco Animal Health
  • Colorado Serum Company
  • Indian Immunologicals Limited
  • Panacea Biotec
  • Biological E Limited
  • Ceva Santé Animale.
Competitive Dashboard Preview
Shortlist strategic accounts and benchmark positioning.
Loading…
Request Competitive Cut

Segmentation Explorer

Interactively explore markets by segment and geography.
Refine View
Opportunity Index
Directional signals for prioritization and scenario framing.
Interactive
Need a board-ready slide? .
Modeling inputs: analyst assumptions, secondary sources, triangulated validations.

Table Of Contents

Expandable preview of coverage and chapter structure.

 

Middle East and Africa Anthrax Vaccine Market Report


  1. 1. Middle East and Africa Anthrax Vaccine Market Research Report
    1. 1.1 Study Objectives
    2. 1.2 Middle East and Africa Anthrax Vaccine Market - Overview
    3. 1.3 Reason to Read This Report
    4. 1.4 Methodology and Forecast Analysis
    2. Middle East and Africa Anthrax Vaccine Market Research Report - Preface
    1. 2.1 Middle East and Africa Anthrax Vaccine Market Research Report – Detailed Scope and Definitions
      1. 2.1.1 By Type
      2. 2.1.2 By Application
      3. 2.1.3 By End-user
      4. 2.1.4 By Region
    3. Middle East and Africa Anthrax Vaccine Market Dynamics
    1. 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
    2. 3.2. Restraints – By Type, By Application, By End-user, By Country
    3. 3.3. Opportunities – By Type, By Application, By End-user, By Country
    4. 3.4. Trends – By Type, By Application, By End-user, By Country
    5. 3.5. PEST Analysis
    6. 3.6. Porters Five Rule Analysis
    7. 3.7. Company’s Share Analysis (CSA) by Region or By Country
    8. 3.8. Middle East and Africa Anthrax Vaccine Market Research Report – DROTs Impact Analysis
    4. Middle East and Africa Anthrax Vaccine Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
    1. 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    2. 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
    3. 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
    4. 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    5. Middle East and Africa Anthrax Vaccine Market, By Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 5.1 Live Attenuated Vaccines
      1. 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 5.2 Inactivated Vaccines
      1. 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 5.3 Recombinant Vaccines
      1. 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. Middle East and Africa Anthrax Vaccine Market, By Application, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 6.1 Pre-exposure Vaccination
      1. 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 6.2 Post-exposure Vaccination
      1. 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    7. Middle East and Africa Anthrax Vaccine Market, By End-user, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 7.1 Military
      1. 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 7.2 Government
      1. 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 7.3 Healthcare Providers
      1. 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    4. 7.4 Others
      1. 7.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    8. Middle East and Africa Anthrax Vaccine Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
    1. 8.1 Middle East & Africa
      1. 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 8.2 Middle East and Africa Anthrax Vaccine Market - Opportunity Analysis Index, By Type, By Application, By End-user, and Region, 2024 - 2031
    9. Middle East & Africa Middle East and Africa Anthrax Vaccine Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 9.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.1.1 Live Attenuated Vaccines
      2. 9.1.2 Inactivated Vaccines
      3. 9.1.3 Recombinant Vaccines
      9.2 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.2.1 Pre-exposure Vaccination
      2. 9.2.2 Post-exposure Vaccination
      9.3 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.3.1 Military
      2. 9.3.2 Government
      3. 9.3.3 Healthcare Providers
      4. 9.3.4 Others
      9.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.4.1 Saudi Arabia
      2. 9.4.2 UAE
      3. 9.4.3 South Africa
      4. 9.4.4 Egypt
      5. 9.4.5 Israel
      6. 9.4.6 Rest of Middle East and Africa
      9.5 Middle East & Africa Middle East and Africa Anthrax Vaccine Market – Opportunity Analysis Index, By Type, By Application, By End-user, and Country, 2024 - 2031
      9.6 Regional Trends Analysis
      9.7 Middle East & Africa Middle East and Africa Anthrax Vaccine Market Research Report - Company Profiles
      1. 9.7.1 Company 1 (Saudi Arabia)
      2. 9.7.2 Company 2 (UAE)
      3. 9.7.3 Company 3 (UAE)
    10. Competition Landscape
    1. 10.1 Strategic Dashboard of Top Market Players
      10.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
      1. 10.2.1 Anthrax Vaccine Market – Emergent BioSolutions Inc.
      2. 10.2.2 Merck & Co. Inc.
      3. 10.2.3 Zoetis Inc.
      4. 10.2.4 Bayer AG
      5. 10.2.5 Elanco Animal Health
      6. 10.2.6 Colorado Serum Company
      7. 10.2.7 Indian Immunologicals Limited
      8. 10.2.8 Panacea Biotec
      9. 10.2.9 Biological E Limited
      10. 10.2.10 Ceva Santé Animale.
    11. Data Collection Method and Research Approach
    12. Principal Presumptions and Acronyms



  2.  

Methodology & Credibility

Built for enterprise decisions, not vanity metrics.
Triangulated Sizing
Bottom-up, top-down, and peer benchmarks reconciled by analysts.
Primary + Secondary Research
Executive interviews combined with validated public and paid sources.
Scenario & Sensitivity
Base, bull and bear cases to stress-test strategic moves.
Need Confidence Fast?
We’ll map your questions to the report in 15 minutes.
Book A Consultation
Preferred by strategy, marketing, and corporate development teams.

Related Reports

More coverage in adjacent themes and segments.
Ready to move from data to decision?
Get the report, request a sample, or book a consultative briefing.
New chat message received
×

Need help?

Chat with our team in a minute.